Logo of jidLink to Publisher's site
PMC full text:

Table 2.

Likelihood of Recovery or Death Based on Baseline Viral Load or Inflammatory Biomarker

RecoveryMortality
Disease Severity: BiomarkerRRR95% CI P ValueHR95% CI P Value
Moderate/severe
Nucleocapsid, log10 pg/mL0.53.42–.66<.0013.921.11–13.86.034
RNA, log10 copies/mL
 Plasma0.41.33–.53<.0014.441.41–13.96.011
 Upper respiratory0.50.40–.64<.0017.801.70–35.82.008
Inflammatory Biomarkers, log10 pg/mL
 CRP0.83.67–1.04.1061.79.65–4.95.259
 IL-60.53.42–.67<.0013.681.32–10.29.013
Critical
Nucleocapsid, log10 pg/mL0.77.58–1.03.0781.07.61–1.87.805
RNA, log10 copies/mL
 Plasma0.58.44–.78<.0011.53.83–2.85.175
 Upper respiratory0.84.63–1.12.2391.12.64–1.98.687
Inflammatory Biomarkers, log10 pg/mL
 CRP0.74.55–1.00.0501.75.93–3.29.085
 IL-60.39.28–.53<.0013.551.41–8.96.007

Cox model estimates of HR for mortality and RRR based on baseline elevation of viral load or inflammatory biomarker (dichotomized at baseline median) when adjusted for treatment arm.

Abbreviations: CRP, C-reactive protein; HR, hazard ratio; IL-6, interleukin 6; RRR, recovery rate ratio